Detalhe da pesquisa
1.
Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression.
Int J Mol Sci;
22(5)2021 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33801310
2.
Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
Carcinogenesis;
39(11): 1399-1410, 2018 12 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30010803
3.
Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid.
Bioorg Med Chem Lett;
26(12): 2829-2833, 2016 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27156773
4.
Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.
Carcinogenesis;
35(3): 692-702, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24193513
5.
Application of a Specific and Sensitive NQO1 Turn-On Near-Infrared Fluorescence Probe for Live Cancer Cell and Xenografted Tumor Imaging in Nude Mice.
Methods Mol Biol;
2755: 63-74, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38319569
6.
Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.
Carcinogenesis;
34(5): 990-1000, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23354308
7.
MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy.
Mol Med;
18: 913-29, 2012 Sep 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22549111
8.
Transcriptional Pausing and Activation at Exons-1 and -2, Respectively, Mediate the MGMT Gene Expression in Human Glioblastoma Cells.
Genes (Basel);
12(6)2021 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34201219
9.
In Vivo Ear Sponge Lymphangiogenesis Assay.
Methods Mol Biol;
2193: 85-96, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32808261
10.
Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach.
Bioconjug Chem;
21(2): 203-7, 2010 Feb 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20063878
11.
Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action.
Cells;
9(7)2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32630235
12.
RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways.
Proteomics;
9(10): 2776-87, 2009 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19405034
13.
Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells.
Int J Oncol;
34(3): 597-608, 2009 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19212664
14.
Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling.
Int J Mol Med;
24(1): 103-10, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19513542
15.
Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
Sci Rep;
9(1): 8577, 2019 06 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31189950
16.
Bap29varP, a variant of Bap29, influences the cell surface expression of the human P-glycoprotein.
Int J Oncol;
32(1): 135-44, 2008 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18097552
17.
Varied expression and localization of multiple galectins in different cancer cell lines.
Oncol Rep;
19(3): 587-94, 2008 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18288388
18.
Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo.
Cancers (Basel);
10(12)2018 Nov 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30487423
19.
S-phase Specific Downregulation of Human O6-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21cip1 Proteins in Glioma Cells.
Neoplasia;
20(4): 305-323, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29510343
20.
Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models.
Oncotarget;
9(40): 26109-26129, 2018 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29899846